BioArray Briefs

Premium

Illumina, Agilent in Resequencing Co-marketing Pact

Illumina and Agilent have entered into a non-exclusive co-marketing agreement focused on researchers conducting targeted resequencing.

The firms jointly announced this week that they will co-market Agilent's SureSelect Target Enrichment System with Illumina's Genome Analyzer. They said the combination will provide researchers with a method for efficiently resequencing specific regions of interest in the genome and will enable researchers to conduct studies that otherwise would not be feasible.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.